BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24420924)

  • 1. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.
    Xu Y; Wang Y; Ma G; Wang Q; Wei G
    J Neurooncol; 2014 Feb; 116(3):625-32. PubMed ID: 24420924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of CUL4A in human prostate cancer.
    Liu G; Zhu Z; Lang F; Li B; Gao D
    Tumour Biol; 2015 Nov; 36(11):8553-8. PubMed ID: 26036759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
    Wang X; Chen T
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
    Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
    Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
    Zhou YZ; Li CZ; Gao H; Zhang YZ
    World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Nakade H; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Miyao S; Sho M
    Int J Clin Oncol; 2020 Mar; 25(3):446-455. PubMed ID: 31535245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.
    Song J; Zhang J; Shao J
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):263-9. PubMed ID: 26055549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
    Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
    Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
    Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of cullin 4A overexpression in human liver cancer.
    Chen G; Zhao X; Tan Z; Wang D; Luo D; Zhang P; Cao J; Wang F; Liu Q; Li L
    Mol Med Rep; 2018 Sep; 18(3):2531-2540. PubMed ID: 30015884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cul4A is an oncogene in malignant pleural mesothelioma.
    Hung MS; Mao JH; Xu Z; Yang CT; Yu JS; Harvard C; Lin YC; Bravo DT; Jablons DM; You L
    J Cell Mol Med; 2011 Feb; 15(2):350-8. PubMed ID: 19929949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
    Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas.
    Onguru O; Scheithauer BW; Kovacs K; Vidal S; Jin L; Zhang S; Ruebel KH; Lloyd RV
    Mod Pathol; 2004 Jul; 17(7):772-80. PubMed ID: 15098012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein in pituitary adenomas.
    Oliveira MC; Marroni CP; Pizarro CB; Pereira-Lima JF; Barbosa-Coutinho LM; Ferreira NP
    Braz J Med Biol Res; 2002 May; 35(5):561-5. PubMed ID: 12011941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.